$CYBN BREAKING: Cybin Initiates First-in-Human Dosing of CYB004 in Phase 1 Clinical Trial https://www.businesswire.com/news/home/20230524005312/en/Cybin-Initiates-First-in-Human-Dosing-of-CYB004-in-Phase-1-Clinical-Trial